Skip to content

OS Therapies OSTX Payments For Fees

Payments For Fees at other companies

RFL
Rafael Holdings, Inc.RFL
$100K
OS Therapies logo
OS TherapiesOSTX
$266.32K+300%
Relmada Therapeutics, Inc. logo
Relmada Therapeutics, Inc.RLMD
$3.5M+7,678%
Jerash Holdings (US), Inc. logo
Jerash Holdings (US), Inc.JRSH
$293.72K+4.4%
Hitachi logo
HitachiHIT
$619K
ROC
Rank One Computing ROC
$5K

Other financials

Income statement

See full
Operating income-$10.2M-103%
Net income-$10.4M-168%
EPS (diluted)-$0.27-50.0%

Balance sheet

See full
Cash & equivalents$917.6K-69.1%
Total debt$20.0M
Total equity-$10.8M-159%
Total assets$7.3M+71.7%

Cash flow

See full
Operating cash flow-$4.6M-32.6%
CapEx$316.4K
Free cash flow-$3.7M

Valuation

See full
Market cap$84.62M+66.4%
Enterprise value$103.7M

Returns & leverage

See full
Return on equity470%
Debt / equity-1.8×
Current ratio0.1×-1.1×

Where this comes from

Reported directly by OS Therapies in its filing.

Tagged under the XBRL concept us-gaap:PaymentsForFees.

The official record: OS Therapies’s 10-Q, filed May 18, 2026, on SEC EDGAR. View the filing →

Ask your AI about OS Therapies's payments for fees.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is OS Therapies's payments for fees?
OS Therapies (OSTX) reported payments for fees of $266.32K in Q1 2026.
How has OS Therapies's payments for fees changed year-over-year?
OS Therapies's payments for fees increased by 300.0% year-over-year, from $66.58K to $266.32K.
What does payments for fees mean?
Total cash outflows directed toward professional, consulting, or administrative service fees. This metric tracks the cost of external expertise required to support business operations and regulatory compliance.